These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 23646490)
1. [Advance of resveratrol in treating diabetes mellitus]. Shen LL; Wang XM; He BL Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):279-81. PubMed ID: 23646490 [No Abstract] [Full Text] [Related]
2. Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action. Abbasi Oshaghi E; Goodarzi MT; Higgins V; Adeli K Crit Rev Clin Lab Sci; 2017 Jun; 54(4):267-293. PubMed ID: 28704113 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol confers endothelial protection in insulin-dependent diabetes mellitus: editorial to: "Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits" by F. Akar et al. Ungvari Z; Csiszar A Cardiovasc Drugs Ther; 2011 Apr; 25(2):111-3. PubMed ID: 20938804 [No Abstract] [Full Text] [Related]
4. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. Palsamy P; Subramanian S J Cell Physiol; 2010 Aug; 224(2):423-32. PubMed ID: 20333650 [TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic effects of resveratrol. Szkudelski T; Szkudelska K Ann N Y Acad Sci; 2011 Jan; 1215():34-9. PubMed ID: 21261639 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Su HC; Hung LM; Chen JK Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1339-46. PubMed ID: 16434553 [TBL] [Abstract][Full Text] [Related]
7. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Elbe H; Vardi N; Esrefoglu M; Ates B; Yologlu S; Taskapan C Hum Exp Toxicol; 2015 Jan; 34(1):100-13. PubMed ID: 24812155 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner. González-Rodríguez Á; Santamaría B; Mas-Gutierrez JA; Rada P; Fernández-Millán E; Pardo V; Álvarez C; Cuadrado A; Ros M; Serrano M; Valverde ÁM Mol Nutr Food Res; 2015 Aug; 59(8):1431-42. PubMed ID: 25808216 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. Gencoglu H; Tuzcu M; Hayirli A; Sahin K Int J Food Sci Nutr; 2015 May; 66(3):314-20. PubMed ID: 25666415 [TBL] [Abstract][Full Text] [Related]
10. Two-dimensional evaluations for mitochondrial number are not reliable. Re: 'neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol' by Jing et al. Akgul EO; Gulcan Kurt Y; Cayci T Neuroendocrinology; 2013; 98(2):169. PubMed ID: 23594587 [No Abstract] [Full Text] [Related]
11. Resveratrol improves hepatic insulin signaling and reduces the inflammatory response in streptozotocin-induced diabetes. Sadi G; Pektaş MB; Koca HB; Tosun M; Koca T Gene; 2015 Oct; 570(2):213-20. PubMed ID: 26071184 [TBL] [Abstract][Full Text] [Related]
12. Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Palsamy P; Subramanian S Chem Biol Interact; 2009 May; 179(2-3):356-62. PubMed ID: 19059388 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Brasnyó P; Molnár GA; Mohás M; Markó L; Laczy B; Cseh J; Mikolás E; Szijártó IA; Mérei A; Halmai R; Mészáros LG; Sümegi B; Wittmann I Br J Nutr; 2011 Aug; 106(3):383-9. PubMed ID: 21385509 [TBL] [Abstract][Full Text] [Related]
14. The cardioprotective effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension. Mozafari M; Nekooeian AA; Mashghoolozekr E; Panjeshahin MR Nat Prod Commun; 2015 Feb; 10(2):335-8. PubMed ID: 25920277 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats. Chen KH; Cheng ML; Jing YH; Chiu DT; Shiao MS; Chen JK Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E853-63. PubMed ID: 21791624 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats. Bai Y; An R Life Sci; 2015 Aug; 135():43-8. PubMed ID: 26006044 [TBL] [Abstract][Full Text] [Related]
17. Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. Schmatz R; Schetinger MR; Spanevello RM; Mazzanti CM; Stefanello N; Maldonado PA; Gutierres J; Corrêa Mde C; Girotto E; Moretto MB; Morsch VM Life Sci; 2009 Mar; 84(11-12):345-50. PubMed ID: 19166862 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats. Roghani M; Baluchnejadmojarad T Phytother Res; 2010 Jun; 24 Suppl 2():S148-54. PubMed ID: 20013818 [TBL] [Abstract][Full Text] [Related]
19. Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats. Hamadi N; Mansour A; Hassan MH; Khalifi-Touhami F; Badary O J Biochem Mol Toxicol; 2012 Oct; 26(10):384-92. PubMed ID: 22791351 [TBL] [Abstract][Full Text] [Related]
20. Ectonucleotidase and acetylcholinesterase activities in synaptosomes from the cerebral cortex of streptozotocin-induced diabetic rats and treated with resveratrol. Schmatz R; Mazzanti CM; Spanevello R; Stefanello N; Gutierres J; Maldonado PA; Corrêa M; da Rosa CS; Becker L; Bagatini M; Gonçalves JF; Jaques Jdos S; Schetinger MR; Morsch VM Brain Res Bull; 2009 Dec; 80(6):371-6. PubMed ID: 19723569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]